ResearcherNanfang HospitalActive in the last 2 years

Rui Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4263-8873; OpenAlex author ID A5100424816. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chungui Xu · 1 shared paper, 2026 · strength 0.43
- Paper A KRAS-ERK-associated model for molecular stratification and prognosis prediction: Highlighting the tumorigenic role of… DOI 10.1016/j.bbrc.2026.154566 ↗
Weihao Lin · 1 shared paper, 2026 · strength 0.43
- Paper A KRAS-ERK-associated model for molecular stratification and prognosis prediction: Highlighting the tumorigenic role of… DOI 10.1016/j.bbrc.2026.154566 ↗
Jing Liu · 1 shared paper, 2017 · strength 0.07
- Paper MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1. DOI 10.1038/s41598-017-11248-3 ↗
Qiu Zhao · 1 shared paper, 2017 · strength 0.07
- Paper MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1. DOI 10.1038/s41598-017-11248-3 ↗
Hongling Wang · 1 shared paper, 2017 · strength 0.07
- Paper MicroRNA-196b inhibits late apoptosis of pancreatic cancer cells by targeting CADM1. DOI 10.1038/s41598-017-11248-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.